Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Helen Jemimah Devanandan"'
Autor:
Helen Jemimah Devanandan, Karthikeyan Muthupandi, Jaishree Pandian, Karthik Balakrishnan, Ponmathi Panneerpandian, Karthikeyan Selvarasu, Kumaresan Ganesan, Balaji T. Sekar
Publikováno v:
Annals of the New York Academy of Sciences. 1467:94-111
The identification of new drugs for the targeted therapy of gastric cancer remains an important need. The RAS/RAF/MEK/ERK/ELK1 signaling cascade is activated in many cancers, including gastric cancer. To identify the targetable inhibitors of the ERK/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4037c5dc33cab955252616665436646
https://doi.org/10.1111/nyas.14288
https://doi.org/10.1111/nyas.14288
Autor:
Julius Xavier Scott, Latha Sneha Magatha, Vettriselvi Venkatesan, Solomon F.D. Paul, Teena Koshy, Helen Jemimah Devanandan
Publikováno v:
Laboratory Medicine. 50:249-253
Background MicroRNAs (miR) have been reported to be involved in hematopoiesis and in the pathogenesis of several hematological malignant neoplasms. Single-nucleotide polymorphisms (SNPs) in human miR genes may alter the expression of those genes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9047e1877935102372b1dbb7bcfd4bb
https://doi.org/10.1093/labmed/lmy074
https://doi.org/10.1093/labmed/lmy074
Publikováno v:
Drug development researchREFERENCES. 82(8)
The oncogenic signaling pathway Wnt is often activated in many cancers including gastric cancer. Wnt signaling pathway is considered as a potential target for developing new targeted therapeutics. Kinase inhibitors are the promising class of drugs fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87975a1d5f0dc20d5d43d45ce561f6e1
https://pubmed.ncbi.nlm.nih.gov/34002415
https://pubmed.ncbi.nlm.nih.gov/34002415
Autor:
C. Karthikeyan, Kumaresan Ganesan, Anantharaj Marimuthu, Ponmathi Panneerpandian, Helen Jemimah Devanandan
Publikováno v:
Antiviral research. 174
Yin Yang 1 (YY1) is a ubiquitous transcription factor with both transcriptional activating and repressing functions. Targeting YY1 is considered as a potential therapeutic strategy for several malignancies. Telomerase Reverse Transcriptase (TERT) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a69e56bd1c0df030b24342b0f23f67
https://pubmed.ncbi.nlm.nih.gov/31846633
https://pubmed.ncbi.nlm.nih.gov/31846633
Autor:
Suresh K. Rayala, Karthik Balakrishnan, Helen Jemimah Devanandan, Balaji T. Sekar, Kumaresan Ganesan, Ponmathi Panneerpandian
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35688cde278ee8032cdb972076cfe789
https://pubmed.ncbi.nlm.nih.gov/31279909
https://pubmed.ncbi.nlm.nih.gov/31279909